These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 3138042
21. Quantitative measurement of lipoprotein particles containing both apolipoprotein AIV and apolipoprotein B in human plasma by a noncompetitive ELISA. Ferrer F, Bigot-Corbel E, N'Guyen P, Krempf M, Bard JM. Clin Chem; 2002 Jun; 48(6 Pt 1):884-90. PubMed ID: 12029004 [Abstract] [Full Text] [Related]
22. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. Brinton EA, Eisenberg S, Breslow JL. J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877 [Abstract] [Full Text] [Related]
23. Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I. Leroy A, Olivier P, Vu-Dac N, Fruchart JC. Clin Chim Acta; 1989 Jan 13; 179(1):85-95. PubMed ID: 2493349 [Abstract] [Full Text] [Related]
24. [The determination of apolipoproteins Apo A-I and Apo B. A comparative study of methods]. Keller H, Riesen WF. Z Med Lab Diagn; 1990 Jan 13; 31(4):200-10. PubMed ID: 2116698 [Abstract] [Full Text] [Related]
26. Urine concentrations of apolipoprotein AI in renal tubular proteinuria. Reichl D, Beetham R. Metabolism; 1988 May 13; 37(5):422-4. PubMed ID: 3130543 [Abstract] [Full Text] [Related]
27. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry. Rosseneu M, Vercaemst R, Vinaimont N, Van Tornout P, Henderson LO, Herbert PN. Clin Chem; 1981 Jun 13; 27(6):856-9. PubMed ID: 6786798 [Abstract] [Full Text] [Related]
28. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I. Atger V, Duval F, Frommherz K, Drüeke T, Lacour B. Atherosclerosis; 1988 Nov 13; 74(1-2):75-83. PubMed ID: 3145749 [Abstract] [Full Text] [Related]
29. Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidation. Wang XL, Dudman NP, Wang J, Wilcken DE. Clin Chem; 1989 Oct 13; 35(10):2082-6. PubMed ID: 2507198 [Abstract] [Full Text] [Related]
33. Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism. Black IW, Wilcken DE. Clin Chem; 1992 Mar 13; 38(3):353-7. PubMed ID: 1547551 [Abstract] [Full Text] [Related]
34. Abnormal concentrations of CII, CIII, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients. Alsayed N, Rebourcet R. Clin Chem; 1991 Mar 13; 37(3):387-93. PubMed ID: 2004445 [Abstract] [Full Text] [Related]
36. Quantification of human serum apolipoprotein AI by enzyme immunoassay. Bury J, Rosseneu M. Clin Chem; 1985 Feb 13; 31(2):247-51. PubMed ID: 3917876 [Abstract] [Full Text] [Related]